We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$13.3M
Cap. Flow
-$5.94M
Cap. Flow %
-5.31%
Top 10 Hldgs %
38.7%
Holding
66
New
2
Increased
18
Reduced
11
Closed
9
Avg Time Held
2.3 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
HAS icon
Hasbro
HAS
+$1.31M
2
CPA icon
Copa Holdings
CPA
+$1.19M
3
FCX icon
Freeport-McMoran
FCX
+$895K
4
OGN icon
Organon & Co
OGN
+$815K
5
PAAS icon
Pan American Silver
PAAS
+$671K

Top Sells

Rank Stock Value
1
KD icon
Kyndryl
KD
+$3.22M
2
PFE icon
Pfizer
PFE
+$1.74M
3
HRI icon
Herc Holdings
HRI
+$1.28M
4
PRGO icon
Perrigo
PRGO
+$1.05M
5
WBD icon
Warner Bros
WBD
+$976K

Sector Composition

Rank Sector Weight
1 Healthcare 39.52%
2 Materials 10.9%
3 Industrials 10.07%
4 Technology 9.2%
5 Financials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
THFF icon
26
First Financial Corp
THFF
$881M
$1.96M 1.75%
42,500
– –
2024 Q1
3 quarters
B icon
27
Barrick Mining
B
$65.3B
$1.94M 1.73%
125,000
– –
2023 Q2
6 quarters
FCX icon
28
Freeport-McMoran
FCX
$97B
$1.9M 1.7%
50,000
+20,000
+67% +$895K
2024 Q3
1 quarter
COHU icon
29
Cohu
COHU
$2.51B
$1.87M 1.67%
70,000
+10,000
+17% +$262K
2024 Q2
2 quarters
JAZZ icon
30
Jazz Pharmaceuticals
JAZZ
$14B
$1.85M 1.65%
15,000
-5,000
-25% -$589K
2024 Q1
3 quarters
EOLS icon
31
Evolus
EOLS
$498M
$1.66M 1.48%
150,000
– –
2023 Q2
6 quarters
PAAS icon
32
Pan American Silver
PAAS
$17.7B
$1.62M 1.44%
80,000
+30,000
+60% +$671K
2023 Q2
6 quarters
XOMA icon
33
DELISTED
Xoma
XOMA
$1.45M 1.29%
55,000
– –
2023 Q4
4 quarters
ACAD icon
34
Acadia Pharmaceuticals
ACAD
$3.4B
$1.28M 1.15%
70,000
– –
2023 Q4
4 quarters
WBA icon
35
DELISTED
Walgreens Boots Alliance
WBA
$1.17M 1.04%
125,000
-75,000
-38% -$696K
2023 Q3
5 quarters
SVC
36
Service Properties Trust
SVC
$828M
$1.14M 1.02%
90,000
+30,000
+50% +$485K
2021 Q3
13 quarters
ELDN icon
37
Eledon Pharmaceuticals
ELDN
$183M
$1.13M 1.01%
275,000
– –
2021 Q1
15 quarters
CVS icon
38
CVS Health
CVS
$118B
$1.12M 1%
25,000
-10,000
-29% -$561K
2024 Q2
2 quarters
HAS icon
39
Hasbro
HAS
$13.8B
$1.12M 1%
+20,000
New +$1.31M
2024 Q4
0 quarters
HRTX icon
40
Heron Therapeutics
HRTX
$74.1M
$1.07M 0.96%
700,000
+200,000
+40% +$324K
2020 Q4
16 quarters
DIT icon
41
AMCON Distributing
DIT
$58.6M
$1.07M 0.95%
12,500
– –
2020 Q4
16 quarters
AVIR icon
42
Atea Pharmaceuticals
AVIR
$377M
$1M 0.9%
300,000
+30,000
+11% +$99.7K
2021 Q2
14 quarters
COYA icon
43
Coya Therapeutics
COYA
$103M
$917K 0.82%
160,000
+15,941
+11% +$109K
2023 Q2
6 quarters
WBD icon
44
DELISTED
Warner Bros
WBD
$740K 0.66%
70,000
-105,000
-60% -$976K
2023 Q2
6 quarters
NKTR icon
45
Nektar Therapeutics
NKTR
$1.3B
$698K 0.62%
50,000
– –
2020 Q4
16 quarters
CRIS icon
46
Curis
CRIS
$1.48M
$673K 0.6%
11,000
+5,000
+83% +$429K
2022 Q4
8 quarters
LTRN icon
47
Lantern Pharma
LTRN
$9.78M
$638K 0.57%
200,000
+15,000
+8% +$51.4K
2022 Q1
11 quarters
CTSO icon
48
Cytosorbents Corp
CTSO
$9.36M
$637K 0.57%
35,000
-5,000
-13% -$98.1K
2021 Q1
15 quarters
OSTX icon
49
OS Therapies Inc
OSTX
$65.5M
$471K 0.42%
110,044
+60,044
+120% +$176K
2024 Q3
1 quarter
FEMY icon
50
Femasys
FEMY
$13.1M
$468K 0.42%
21,250
– –
2021 Q2
14 quarters
1
2
3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q4 2024 Portfolio in Review

As of Q4 2024, CM Management held 66 positions worth $112M, down 11% from $125M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CM Management withdrew a net $5.94M in Q4 2024, closing 9 positions and reducing 11 holdings. Its most notable exit was Kyndryl, an estimated $3.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 40% a quarter earlier, followed by Materials and Industrials.

Against the trend, CM Management opened a new position in Hasbro worth $1.12M.

  • CM Management's largest Q4 2024 buy was Hasbro: 20,000 shares worth $1.12M.
  • CM Management added most to Copa Holdings in Q4 2024, an estimated $1.19M increase.
  • CM Management's biggest Q4 2024 reduction was Warner Bros, cutting an estimated $976K.
  • CM Management fully exited Kyndryl in Q4 2024, selling an estimated $3.22M.
  • CM Management's ten largest holdings make up 39% of its $112M portfolio in Q4 2024.
  • CM Management opened 2 new positions and closed 9 in Q4 2024.
  • CM Management's portfolio value fell 11% quarter-over-quarter to $112M.

Based on CM Management's 13F filing for Q4 2024, filed 7 Feb 2025.